Literature DB >> 33580932

Ozenoxacin: A novel topical antibiotic.

Parvathy Santhosh1, Mithun Harold Thomas2.   

Abstract

Entities:  

Year:  2021        PMID： 33580932     DOI： 10.25259/IJDVL_191_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  25 in total

Review 1.  Impetigo: an update.

Authors:  Justin Brown; David L Shriner; Robert A Schwartz; Camila K Janniger
Journal:  Int J Dermatol       Date:  2003-04       Impact factor: 2.736

2.  Ozenoxacin: A Novel Drug Discovery for the Treatment of Impetigo.

Authors:  Jagdish K Sahu; Arun K Mishra
Journal:  Curr Drug Discov Technol       Date:  2019

Review 3.  Retapamulin: a novel topical antibiotic.

Authors:  H Nagabushan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Jan-Feb       Impact factor: 2.545

Review 4.  Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA.

Authors:  T Poovelikunnel; G Gethin; H Humphreys
Journal:  J Antimicrob Chemother       Date:  2015-07-03       Impact factor: 5.790

Review 5.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

6.  Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin.

Authors:  M C Bastos; P J Mondino; M L Azevedo; K R Santos; M Giambiagi-deMarval
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-06       Impact factor: 3.267

7.  Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center.

Authors:  Tara Babu; Violeta Rekasius; Jorge P Parada; Paul Schreckenberger; Malliswari Challapalli
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

8.  In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.

Authors:  Y López; M Tato; P Espinal; F Garcia-Alonso; D Gargallo-Viola; R Cantón; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

Review 9.  Mechanism of action of and resistance to quinolones.

Authors:  Anna Fàbrega; Sergi Madurga; Ernest Giralt; Jordi Vila
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

10.  Activities of gyrase and topoisomerase IV on positively supercoiled DNA.

Authors:  Rachel E Ashley; Andrew Dittmore; Sylvia A McPherson; Charles L Turnbough; Keir C Neuman; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.